Sol-Gel’s new investigational microencapsulated benzoyl peroxide and tretinoin combination cream, Twyneo, for the treatment of acne vulgaris shows promising results from recently released phase 3 data with both clinical trials meeting all primary endpoints.
Early results from the first patients treated for back acne with Nano-Pulse Stimulation in a controlled study show that use of this nonthermal energy modality is providing rapid and sustained clearance of inflammatory lesions, reported Mark Nestor, M.D., Ph.D., at the 2019 annual meeting of the American Society for Dermatologic Surgery.
Trifarotene may become the European Union’s first new retinoid molecule acne treatment for the face and trunk in 25 years following upcoming individual member state marketing approvals in 2020.
The choice of treatment for acne in adolescence may impact the risk of later scar formation when the condition persists into adulthood, shows a recent study.
Treating all acne early with a topical retinoid and an antibiotic can help patients avoid scarring and its psychosocial consequences, experts say. The aggressive approach also may help stave off medicolegal concerns, they add.
Studies support using microneedling as monotherapy to treat acne scars; however, mixed evidence requires more direct comparisons with other minimally invasive treatments.
A 40mg doxycycline dose with a topical containing adapalene 0.3% and benzoyl peroxide 2.5% is an effective and safe treatment option for severe acne, according to a single-center pilot study published recently.
To recognize Antibiotic Awareness Week, we’ve gathered articles on antibiotic use in acne, alternative therapies and treatment trends in the specialty. View the highlights in this slideshow.
Adult female acne should be treated differently than teenage acne. There is a hormonal component at play rather than a bacterial pathogenesis that should be considered, one expert says.
Several retrospective analyses indicate spironolactone may have similar efficacy to oral antibiotics in the treatment of acne in women. Underuse of this off-label treatment option may be due to lack of efficacy evidence. The two options should be directly evaluated in future studies to guide practice.